References
- KurzenHKurokawaIJemecGBWhat causes hidradenitis suppurativa?Exp Dermatol20081745547218400064
- NaldiLEpidemiologyJemecGRevuzJLeydenJJHidradenitis SuppurativeBerlinSpringer20065864
- AlikhanALynchPJEisenDBHidradenitis suppurativa: a comprehensive reviewJ Am Acad Dermatol200960453956119293006
- RevuzJECanoui-PoitrineFWolkensteinPPrevalence and factors associated with hidradenitis suppurativa: results from two case-control studiesJ Am Acad Dermatol20085959660118674845
- JemecGBHeidenheimMNielsenNHThe prevalence of hidradenitis suppurativa and its potential precursor lesionsJ Am Acad Dermatol1996351911948708018
- JemecGBThe symptomatology of hidradenitis suppurativa in womenBr J Dermatol19881193453503179207
- VazquezBGAlikhanAWeaverALWetterDADavisMDIncidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, MinnesotaJ Invest Dermatol20131339710322931916
- CosmatosIMatchoAWeinsteinRMontgomeryMOStangPAnalysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United StatesJ Am Acad Dermatol20136841241922921795
- MargessonLJDanbyFWHidradenitis suppurativaBest Pract Res Clin Obstet Gynaecol2014281013102725214437
- EsmannSDufourDNJemecGBQuestionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questionsBr J Dermatol201016310210620331444
- ZouboulisCCDesaiNEmtestamLEuropean S1 guideline for the treatment of hidradenitis suppurativa/acne inversaJ Eur Acad Dermatol Venereol20152961964425640693
- de WinterKvan der ZeeHHPrensEPIs mechanical stress an important pathogenic factor in hidradenitis suppurativa?Exp Dermatol20122117617722379963
- SchraderAMDeckersIEvan der ZeeHHBoerJPrensEPHidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severityJ Am Acad Dermatol20147146046724880664
- FitzsimmonsJSGuilbertPRA family study of hidradenitis suppurativaJ Med Genet1985223673732934550
- PinkAESimpsonMADesaiNMutations in the gamma-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa)J Invest Dermatol20121322459246122622421
- WangBYangWWenWGamma-secretase gene mutations in familial acne inversaScience2010330106520929727
- PinkAESimpsonMADesaiNTrembathRCBarkerJNGamma-secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesisJ Invest Dermatol201313360160723096707
- ScheinfeldNHidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patientsDermatol Online J2013191
- PrensEDeckersIPathophysiology of hidradenitis suppurativa: an updateJ Am Acad Dermatol2015735 Suppl 1S8S1126470623
- JemecGBThomsenBMHansenUThe homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variationAPMIS19971053783839201239
- JemecGBHansenUHistology of hidradenitis suppurativaJ Am Acad Dermatol1996349949998647993
- von LaffertMHelmboldPWohlrabJFiedlerEStadieVMarschWCHidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermisExp Dermatol20101953353719659829
- BoerJWeltevredenEFHidradenitis suppurativa or acne inversa. A clinicopathological study of early lesionsBr J Dermatol19961357275
- KampSFiehnAMStenderupKHidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativaBr J Dermatol201116451017102221250966
- KathjuSLaskoLAStoodleyPConsidering hidradenitis suppurativa as a bacterial biofilm diseaseFEMS Immunol Med Microbiol201265238538922353357
- Guet-RevilletHCoignard-BiehlerHJaisJPBacterial pathogens associated with hidradenitis suppurativa, FranceEmerg Infect Dis201420121990199825418454
- MatusiakLBieniekASzepietowskiJCBacteriology of hidradenitis suppurativa – which antibiotics are the treatment of choice?Acta Derm Venereol201494669970224604152
- HofmannSCSaborowskiVLangeSKernWVBruckner-TudermanLRiegSExpression of innate defense antimicrobial peptides in hidradenitis suppurativaJ Am Acad Dermatol20126696697421982063
- EmelianovVUBecharaFGGläserRImmunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversaBr J Dermatol20121661023103422136668
- BecharaFGSandMSkryganMKreuterAAltmeyerPGambichlerTAcne inversa: evaluating antimicrobial peptides and proteinsAnn Dermatol20122439339723197903
- MammucariCTommasi di VignanoASharovAAIntegration of Notch 1 and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation controlDev Cell2005866567615866158
- MelnikBCPlewigGImpaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biologyExp Dermatol20132217217723489419
- RangarajanATaloraCOkuyamaRNotch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiationEMBO J2001203427343611432830
- PanYLinMHTianXGamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesisDev Cell2004773174315525534
- van der ZeeHHLamanJDde RuiterLDikWAPrensEPAdalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo studyBr J Dermatol201216629830522013960
- HungerRESurovyAMHassanASBraathenLRYawalkarNToll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptorBr J Dermatol200815869169718241264
- ReFStromingerJLToll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cellsJ Biol Chem2001276376923769911477091
- SchlapbachCHänniTYawalkarNHungerREExpression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativaJ Am Acad Dermatol20116579079821641076
- Giamarellos-BourboulisEJAntonopoulouAPetropoulouCAltered innate and adaptive immune responses in patients with hidrad-enitis suppurativaBr J Dermatol2007156515617199566
- ZhangQWangCLiuZNotch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor κB activationJ Biol Chem20122876208621722205705
- MozeikaEPilmaneMNürnbergBMJemecGBTumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativaActa Derm Venereol20139330130423096596
- van der ZeeHHLamanJDBoerJPrensEPHidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatmentsExp Dermatol20122173573922882284
- KathjuSLaskoLStoodleyPConsidering hidradenitis suppurativa as a bacterial biofilm diseaseFEMS Immunol Med Microbiol20126538538922353357
- JahnsACKillasliHNosekDMicrobiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patientsAPMIS201412280480924475943
- YuCCCookMGHidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glandsBr J Dermatol19901227637692369556
- EsmannSJemecGBPsychosocial impact of hidradenitis suppurativa: a qualitative studyActa Derm Venereol20119132833221394419
- BrownTJRosenTOrengoIFHidradenitis suppurativaSouth Med J199891110711149853721
- SladeDEMPowellBWMortimerPSHidradenitis suppurativa: pathogenesis and managementBr J Plast Surg20035645146112890458
- ShalomGFreudTHarman-BoehmIPolishchukICohenADHidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patientsBr J Dermatol2015173246447025760289
- RevuzJHidradenitis suppurativaJ Eur Acad Dermatol Venereol200923998599819682181
- KimballABKerdelFAdamsDAdalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trialAnn Intern Med201215784685523247938
- SartoriusKKillasliHHeilbornJJemecGBLapinsJEmtestamLInterobserver variability of clinical scores in hidradenitis suppurativa is lowBr J Dermatol20101621261126820184581
- AmanoMGrantAKerdelFAA prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativaInt J Dermatol20104995095521128923
- JemecGBBiomarkers in hidradenitis suppurativaBr J Dermatol201316811511153
- HurleyHJAxillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approachRoenigkRKRoenigkHHDermatologic SurgeryNew YorkMarcel Dekker1996623645
- SartoriusKEmtestamLJemecGBLapinsJObjective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesityBr J Dermatol200916183183919438453
- SartoriusKLapinsJEmtestamLJemecGBSuggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativaBr J Dermatol200314921121312890229
- GrantAGonzalezTMontgomeryMOCardenasVKerdelFAInfliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trialJ Am Acad Dermatol20106220521720115947
- PascoeVLKimballABHidradenitis suppurativa: current progress and future questionsJAMA Dermatol20141501263126425229429
- GoldDAReederVJMahanMGHamzaviIHThe prevalence of metabolic syndrome in patients with hidradenitis suppurativaJ Am Acad Dermatol20147069970324433875
- ShlyankevichJChenAJKimGEKimballABHidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysisJ Am Acad Dermatol20147161144115025440440
- MillerIMEllervikCVindingGRAssociation of metabolic syndrome and hidradenitis suppurativaJAMA Dermatol20141501273128025229996
- DeckersIEBenhadouFKoldijkMJInflammatory bowel disease is associated with hidradenitis suppurativa: results from a multicenter cross-sectional studyJ Am Acad Dermatol2017761495327793450
- NapolitanoMMegnaMMonfrecolaGInsulin resistance and skin diseasesScientific World J20152015479354
- BettoliVNaldiLCazzanigaSOverweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa–acne inversa. Evidence from the national Italian registryBr J Dermatol2016174119519725913460
- MonfrecolaGBalatoACaiazzoGMammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loopJ Eur Acad Dermatol Venereol20163091631163326299257
- TianGLiangJNWangZYZhouDEmerging role of leptin in rheumatoid arthritisClin Exp Immunol201417755757024802245
- SabatRChanwangpongASchneider-BurrusSIncreased prevalence of metabolic syndrome in patients with acne inversaPLoS One20127e3181022359634
- EgebergAGislasonGHHansenPRRisk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativaJAMA Dermatol2016152442943426885728
- MillerIMMcAndrewRJHamzaviIPrevalence, risk factors, and comorbidities of hidradenitis suppurativaDermatol Clin201634171626617352
- ShavitEDreiherJFreudTHalevySVinkerSCohenADPsychiatric comorbidities in 3207 patients with hidradenitis suppurativaJ Eur Acad Dermatol Venereol20152937137624909646
- OnderdijkAJvan der ZeeHHEsmannSDepression in patients with hidradenitis suppurativaJ Eur Acad Dermatol Venereol201327447347822339940
- YadavSSinghSEdakkanambeth VarayilJHidradenitis suppurativa in patients with inflammatory bowel disease: a population-based cohort study in Olmsted County, MinnesotaClin Gastroenterol Hepatol2016141657025952308
- KamalNCohenBLBucheSDelaporteEColombelJFFeatures of patients with Crohn’s disease and hidradenitis suppurativaClin Gastroenterol Hepatol2016141717925956836
- HsiaoJLAntayaRJBergerTMaurerTShinkaiKLeslieKSHidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature reviewArch Dermatol2010146111265127021079064
- RichettePMoltoAViguierMHidradenitis suppurativa associated with spondyloarthritis – results from a multicenter national prospective studyJ Rheumatol20144149049424429166
- BhallaRSequeiraWArthritis associated with hidradenitis suppurativaAnn Rheum Dis19945364668311560
- VasanthVChandrashekarBSFollicular occlusion tetradIndian Dermatol Online J2014549149325396138
- ConstantinouCWidomKDesantisJObmannMHidradenitis suppurativa complicated by squamous cell carcinomaAm Surg200874121177118119097532
- ScheinfeldNA case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinomaDermatol Online J2014203
- ClemmensenOJTopical treatment of hidradenitis suppurativa with clindamycinInt J Dermatol1983223253286347922
- JemecGBEWendelboePTopical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativaJ Am Acad Dermatol1998399719749843011
- GenerGCanoui-PoitrineFRevuzJECombination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patientsDermatology200921914815419590173
- MendoncaCOGriffithsCEClindamycin and rifampicin combination therapy for hidradenitis suppurativaBr J Dermatol200615497797816634904
- van der ZeeHHBoerJPrensEPJemevJBThe effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativaDermatology200921914314719590174
- BettoliVZauliSBorghiAOral clindamycin and rifampicin in the treatment of hidradenitis suppurativa–acne inversa: a prospective study on 23 patientsJ Eur Acad Dermatol Venereol20142812512623451831
- DessiniotiCZisimouCTzanetakouVStratigosAAntoniouCOral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-upClin Exp Dermatol201641885285727753139
- Join-LambertOCoignardHJaisJPEfficacy of rifampin–moxifloxacin–metronidazole combination therapy in hidradenitis suppurativaDermatology20112221495821109728
- Join-LambertOCoignard-BiehlerHJaisJPEfficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patientsJ Antimicrob Chemother201671251352026565016
- MeixnerDSchneiderSKrauseMSterryWAcne inversaJ Dtsch Dermatol Ges2008618919618093218
- BoerJNazaryMLong-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?Br J Dermatol201116417017520874789
- MatusiakLBieniekASzepietowskiJCAcitretin in hidradenitis suppurativa treatment – own experiencesPrzegl Dermatol201299356357
- TanMGShearNHWalshSAlhusayenRAcitretin: monotherapy or combined therapy for hidradenitis suppurativa?J Cutan Med Surg2016211485327432818
- ChowETMortimerPSSuccessful treatment of hidradenitis suppurativa and retroauricular acne with etretinateBr J Dermatol1992126415
- HoganDJLightMJSuccessful treatment of hidradenitis suppurativa with acitretinJ Am Acad Dermatol1988193553562971689
- SchemanAJNodulocystic acne and hidradenitis suppurativa treated with acitretin: a case reportCutis20026928728812080949
- VahlquistAGriffithsWRetinoid therapy in hidradenitis suppurativa – a report of a caseRetinoids Today Tom1990182830
- GuptaAKEllisCNNickoloffBJOral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysisArch Dermatol19901263393502178558
- RoseRFGoodfieldMJClarkSMTreatment of recalcitrant hidradenitis suppurativa with oral ciclosporinClin Exp Dermatol20063115415516309527
- BuckleyDARogersSCyclosporin-responsive hidradenitis suppurativaJ R Soc Med199588289290
- AndersonMDZauliSBettoliVBoerJJemecGBCyclosporine treatment of severe hidradenitis suppurativa – a case seriesJ Dermatolog Treat201627324725026406923
- YazdanyarSBoerJIngvarssonGSzepietowskiJCJemecGBDapsone therapy for hidradenitis suppurativa: a series of 24 patientsDermatology201122234234621757878
- KaurMRLewisHMHidradenitis suppurativa treated with dapsone: a case series of five patientsJ Dermatolog Treat20061721121316971313
- HoferTItinPHAcne inversa: a dapsone-sensitive dermatosisHautarzt200152989992 German11715401
- SoriaACanoui-PoitrineFWolkensteinPAbsence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients’ outcome assessmentDermatology200921813413519060466
- BoerJMirjanJPGemertVLong-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativaJ Am Acad Dermatol19994073769922015
- NorrisJFCunliffeWJFailure of treatment of familial widespread hidradenitis suppurativa with isotretinoinClin Exp Dermatol1986115795833478160
- JemecGGEGniadeckaMSebum excretion in hidradenitis suppurativaDermatology19971943253289252751
- HaslundPLeeRAJemecGBTreatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitorsActa Derm Venereol20098959560019997689
- MegnaMBettoliVChimentiSHidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agentsG Ital Dermatol Venereol2015150673173926513043
- ShujaFChanCSRosenTBiologic drugs for the treatment of hidradenitis suppurativa: an evidence-based reviewDermatol Clin20102851152420510761
- van RappardDCMooijJEBaetenDLMekkesJRNew-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximabBr J Dermatol201116519419821428974
- BrunassoAMDelfinoCMassoneCHidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative?Br J Dermatol200815976176318627370
- DelageMSamimiMAtlanMMachetLLoretteGMaruaniAEfficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markersActa Derm Venereol20119116917121384087
- FardetLDupuyAKerobDInfliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patientsJ Am Acad Dermatol20075662462817240478
- Fernandez-VozmedianoJMArmario-HitaJCInfliximab for the treatment of hidradenitis suppurativaDermatology2007215414417587838
- LasockiASinclairRFoleyPSaundersHHidradenitis suppurativa responding to treatment with infliximabAustralas J Dermatol20105118619020695857
- MekkesJRBosJDLong-term efficacy of a single course of infliximab in hidradenitis suppurativaBr J Dermatol200815837037418047504
- ParadelaSRodriguez-LojoRFernandez-TorresRArévaloPFonsecaELong-term efficacy of infliximab in hidradenitis suppurativaJ Dermatolog Treat20122327828322482700
- PedrazJDaudenEPerez-GalaSGoiriz-ValdésRFernández-PeñasPGarcía-DiezAHidradenitis suppurativa. Response to treatment with infliximabActas Dermosifiliogr200798325331 Spanish17555675
- UsmaniNClaytonTHEverettSGoodfieldMDVariable response of hidradenitis suppurativa to infliximab in four patientsClin Exp Dermatol20073220420517342798
- ArenbergerovaMGkalpakiotisSArenbergerPEffective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapyInt J Dermatol2010491445144921091684
- BlancoRMartinez-TaboadaVMVillaILong-term successful adalimumab therapy in severe hidradenitis suppurativaArch Dermatol200914558058419451504
- SotiriouEApallaZVakirlisEIoannidesDEfficacy of adalimumab in recalcitrant hidradenitis suppurativaEur J Dermatol20091918018119153066
- YamauchiPSMauNHidradenitis suppurativa managed with adalimumabJ Drugs Dermatol2009818118319213236
- AbbVieA phase 3 multicenter study of the safety and efficacy of adalimumab in subjects with moderate to severe hidradenitis suppurativa – PIONEER I ClinicalTials.gov, Identifier: NCT01468207 [last updated October 15, 2015]. Available from: https://clinicaltrials.gov/ct2/show/NCT01468207?term=NCT01468207&rank=1Accessed May 23, 2016
- AbbVieA phase 3 multicenter study of the safety and efficacy of adalimumab in subjects with moderate to severe hidradenitis suppurativa – PIONEER II ClinicalTials.gov, Identifier: NCT01468233 [last updated October 15, 2015]. Available from: https://clinicaltrials.gov/ct2/show/NCT01468233?term=NCT01468233&rank=1Accessed May 23, 2016
- KimballABOkunMMWilliamsDATwo phase 3 trials of adalimumab for hidradenitis suppurativaN Engl J Med2016375542243427518661
- BlokJLLiKBrodmerkelCHorvátovichPJonkmanMFHorváthBUstekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serumBr J Dermatol2016174483984626641739
- GulliverWPJemecGBBakerKAExperience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativaJ Eur Acad Dermatol Venereol201226791191421605174
- SharonVRGarciaMSBagheriSManagement of recalcitrant hidradenitis suppurativa with ustekinumabActa Derm Venereol201292332032122101775
- BaerveldtEMKappenJHThioHBvan LaarJAvan HagenPMPrensEPSuccessful long-term triple disease control by ustekinumab in a patient with Behcet’s disease, psoriasis and hidradenitis suppurativaAnn Rheum Dis201372462662723148307
- Santos-PérezMIGarcía-RodicioSDel Olmo-RevueltoMAPozo-RománTUstekinumab for hidradenitis suppurativa: a case reportActas Dermosifiliogr2014105772072224308927